Sjogren’s syndrome is an inflammatory disorder characterized by lymphocytic infiltrates in exocrine organs, primarily in lacrimal and salivary glands, resulting in classic sicca symptoms of dry mouth (xerostomia) and dry eyes (xerophthalmia). Etiology of the disorder is unknown though finding suggests interaction between innate immunity and acquired immunity may lead to develop Sjogren’s syndrome. Worldwide, it affects one to two million people. In the U.S.  Sjogren’s syndrome is the second most common rheumatic disorder. This disorder can affect individuals of any age, but it is most common in elderly people (prevalence of about 3% above the age of 50 years). It affects primarily women as compared to men. The disorder segmented into primary and secondary. The disorder that occurs in the absence of other autoimmune disease, such as lupus, rheumatoid arthritis, or scleroderma is known as primary Sjogren's syndrome. The one that occurs due to presence of other autoimmune diseases is known as secondary Sjogren's syndrome.

The Sjogren's syndrome market is growing as no single therapy is approved for both primary and secondary Sjogren's syndrome. Most of the treatment for Sjogren's syndrome is aimed at relieving symptoms such as dry mouth (saliva stimulants), gastric reflux (proton pump inhibitors or H2 blockers), infection (antifungals), and dry eyes (artificial tears). Corticosteroids and immunosuppressive agents are also used for the treatment of this disorder.  Researchers such as Bristol-Myers Squibb Company and Biogen Inc. are now evaluating biological therapies for the treatment of Sjogren's syndrome. In addition, therapeutics such as abatacept and belimumab are under clinical development. As of March 2017, clinical pipeline of Sjogren’s syndrome consists of 42 drug molecules, out of which 38% are biologics, 35% are small molecules, 10% are fusion protein, and 16% are others (protein, peptide, recombinant protein, and devices).

The global Sjogren's syndrome market has been segmented by indication, product type, application, and geography. In terms of indication, the market has been categorized into primary Sjogren’s syndrome and secondary Sjogren’s syndrome. The secondary Sjogren’s syndrome segment market dominated over the primary Sjogren’s syndrome segment due to increased incidence and prevalence rate of other autoimmune diseases (lupus, rheumatoid arthritis or scleroderma). Based on product type, the market has been segmented into small molecules, biologics, and others. The biologics segment expected to grow as compared to other therapeutic segments because owing to the limitation in current treatment options In addition, majority of pipeline molecules for the treatment of Sjogren’s syndrome are biologics, which has shown more promising results in clinical development. Based on application, the market has been segmented on the basis of symptomatic treatment such as dry eyes, dental care, vaginal dryness, musculoskeletal, and others.

Geographically, the global Sjogren’s syndrome market is classified into five regions namely; North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The Europe and North America markets are expected to grow as compared to the Asia Pacific, and Middle East & Africa markets due to higher prevalence rate, increase in the number of other autoimmune diseases (lupus, rheumatoid arthritis, or scleroderma), rise in demand for advance treatment, and increase in geriatric population. Asia Pacific is an emerging market due to developing health care infrastructure and rising government expenditure in the health care industry. In addition, increased incidences of Sjogren’s syndrome and rise in diagnosis rates are key factors driving the growth of the Asia Pacific market. However, affordability, lack of proper treatment, and poor patient education restraining the growth of the Sjogren’s syndrome market in developing and undeveloped regions such as Middle East & Africa and Latin America.

Major key players with strong product portfolio for the treatment of Sjogren’s syndrome include, Kissei Pharmaceutical, Novartis AG, Aldeyra Therapeutics, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Amgen Inc., and Biogen, Inc.

This upcoming business intelligence report is intended to be a one-stop market research solution to guide organizations in taking timely and effective decisions for their business growth. The ongoing study is the culmination of our deep expertise on data science methods, combined with an unparalleled understanding of the external environment and analysis of the industries. Each of the reports by TMR aims at offering a detailed scrutiny of the value chain of our current and prospective customers, takes them from identifying value propositions, and subsequently assist their business executives to implement right strategies to create customer value. We believe that creating and sustaining the customer value is the key pivot on which business executives can create profits for their organizations and increase the market shares, continuously and with sustainability.

Each of our touchpoints through which we engage with the organization/enterprise during the primary research enables us to understand the internal environment it operates in and the ways in which the external environment influences its growth.

Always Evolving with Competition

Excellence is built into the DNA of TMR, and all our teams work collaboratively and committedly toward achieving that in whatever they do. From the very first interaction our teams of research analysts have with any interested market participant to the final preparation processes in each of our reports reflects a rigorous understanding of the dynamic industry environment that businesses operate in.

We relentlessly work to be a differentiator in whatever we do in the current era of hypercompetitive global environment. The result of our unceasing focus on excellence is reflected clearly in the insights and guidance we offer to our customers in order to empower them to create brand equity. Our simple yet very powerful underpinning for navigating the competition is to always keep evolving with changing business environments. Our close-kinit team of research analysts not only believe in this simple philosophy but also implement the same.

Constantly Innovating Our Research Methodologies and Models

We do not limit with any specific market research tool or one standard approach for obtaining or analyzing data. Undoubtedly, our report making process is ever-evolving to meet the customer needs and demands supported broadly by a vast knowledge of data science methods that we combine with business acumen our teams have built upon for several years. Evidently, our primary and secondary research data about customers and consumers have shown that we can go to any lengths to obtain them. This is followed by applying next-gen automation tools integrated with human judgement to clear the clutter, ascertain the most relevant and recent qualitative and quantitative insights, and package them in digestible chunks in our reports for our customers.

We Take Pride in No-One-Size-Fits-All Approach

Over the past several years, we have been conducting market intelligence studies across all industries for all types of organizations — big and small, profit and not-for-profit, and Fortune 500 and Unicorns, as we believe that a sound decision making must be based on no-one-size-fits-all approach. Without doubt, each of the organizations regardless of the industry they are in are affected differently by changes in political, economic, socio-culture, legal, ecological, and legal environments. The research models and the value chain analysis process that our analysts employ for conducting the study uphold this approach.

We look at myriad components of internal and external business environment affecting the growth strategies of organizations. Some of the broader aspects that we focus on are:

  • Our team of Analysts and Support Teams always strive to see the bigger picture in life cycle stages of any industry
  • The Teams focus on obtaining valuable insights into different models of competitive advantage while making an internal environment analysis
  • They keep on modifying the value chain analysis processes of organizations to understand on how customer value is created

Some areas of assessing market dynamics that are used in the research models and methodologies adopted by our analysts can be summarized as:

  • Corporate and business strategies underlying new brand positioning strategies
  • Mapping for strategic planning for business units
  • Various metrics for business portfolio analysis, including BCG matrix
  • Value chain analysis

These will help create and sustain competitive advantage for our prospects and current customers.

Key focus areas and agenda that underpin and catalyze our primary and secondary research initiatives and endeavors are:

  • What are some of the core competencies and distinctive competencies of new entrants and established players in the industry we are analyzing?
  • What are some of the branding opportunities that are emerging at a rapid pace?
  • What are the major competitive forces and elements of external environment shaping the industry life cycle stages of most organizations?
  • Why some competitive strategies are popular than others among leaders in a certain market?
  • What customer-based brand equity strategies companies have leveraged in a certain industry or set of related industries in a sector?
  • What are some of the key pricing strategies that companies in an industry are implementing for marketing their products internationally?
  • Identifying whether market-push or market-pull strategies are more relevant to a certain product or a service?

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Sjogren's Syndrome Market